Takeda Becomes Bank Borrower To Cover Nycomed Acquisition
This article was originally published in PharmAsia News
Executive Summary
Takeda Pharmaceutical, once considered a cash-heavy firm, plans to borrow about $7.7 billion to finance its acquisition of Nycomed of Switzerland